"Research use only" (RUO) is a real regulatory category, not a slogan. It describes products, including research chemicals and peptides, that are supplied for laboratory and research purposes, not for diagnostic, therapeutic, veterinary, or human consumption use. It is a legitimate, commonly used label across the life sciences supply chain.
What it isn't is a shield that makes the label itself the whole story. In warning letters issued throughout 2026, the FDA made clear that it evaluates a seller by everything the seller says and does, including marketing language, customer communications, implied use cases, and dosing suggestions, not by the RUO label in isolation.
In practice, that means a seller can put "research use only" on a product and still attract regulatory scrutiny if other parts of the business, such as product descriptions implying a health benefit, customer support answering dosing questions, or marketing that targets individual consumers rather than labs, contradict that label. The label describes intended use; it doesn't override what the rest of the operation communicates.
For a reader trying to judge a seller, the useful question isn't whether they say research use only (almost everyone in this space does), but whether everything else about how they operate is actually consistent with that claim.